Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
Brouillette RL, Besserer-Offroy É, Mona CE, Chartier M, Lavenus S, Sousbie M, Belleville K, Longpré JM, Marsault É, Grandbois M, Sarret P.
Brouillette RL, et al. Among authors: sousbie m.
Pharmacol Res. 2020 May;155:104750. doi: 10.1016/j.phrs.2020.104750. Epub 2020 Mar 6.
Pharmacol Res. 2020.
PMID: 32151680